Cargando…
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment
Chronic inflammation is believed to play an important role in the development and disease progression of polycythemia vera (PV). Because an association between gut microbiota, hematopoiesis, and inflammation is well established, we hypothesized that patients with PV have a gut microbiota distinct fr...
Autores principales: | Eickhardt-Dalbøge, Christina Schjellerup, Ingham, Anna Cäcilia, Andersen, Lee O'Brien, Nielsen, Henrik V., Fuursted, Kurt, Stensvold, Christen Rune, Larsen, Morten Kranker, Kjær, Lasse, Christensen, Sarah Friis, Knudsen, Trine Alma, Skov, Vibe, Ellervik, Christina, Olsen, Lars Rønn, Hasselbalch, Hans Carl, Nielsen, Xiaohui Chen, Christensen, Jens Jørgen Elmer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362542/ https://www.ncbi.nlm.nih.gov/pubmed/36260736 http://dx.doi.org/10.1182/bloodadvances.2022008555 |
Ejemplares similares
-
Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemia
por: Eickhardt-Dalbøge, Christina Schjellerup, et al.
Publicado: (2023) -
Proteomic identification of proliferation and progression markers in human polycythemia vera stem and progenitor cells
por: Tan, Ge, et al.
Publicado: (2022) -
Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms
por: Skov, Vibe, et al.
Publicado: (2022) -
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses
por: Knudsen, Trine Alma, et al.
Publicado: (2022) -
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives
por: Hasselbalch, Hans, et al.
Publicado: (2022)